{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:09:57Z","timestamp":1773209397454,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11064-022-03848-x","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T03:02:43Z","timestamp":1672369363000},"page":"1280-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review"],"prefix":"10.1007","volume":"48","author":[{"given":"Mahin","family":"Behzadifard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Aboutaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Dolatshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Khorramizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamzeh","family":"Mirshekari Jahangiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynab","family":"Kord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donya","family":"Nazarinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"3848_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"\u00c1 Chamorro","year":"2016","unstructured":"Chamorro \u00c1, Dirnagl U, Urra X, Planas AM (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15:869\u2013881","journal-title":"Lancet Neurol"},{"key":"3848_CR2","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.2147\/IJN.S210035","volume":"14","author":"H Amani","year":"2019","unstructured":"Amani H, Mostafavi E, Alebouyeh MR, Arzaghi H, Akbarzadeh A, Pazoki-Toroudi H, Webster TJ (2019) Would colloidal gold nanocarriers present an effective diagnosis or treatment for ischemic stroke? Int J Nanomed 14:8013","journal-title":"Int J Nanomed"},{"key":"3848_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6983","author":"MS Phipps","year":"2020","unstructured":"Phipps MS, Cronin CA (2020) Management of acute ischemic stroke. Bmj. https:\/\/doi.org\/10.1136\/bmj.l6983","journal-title":"Bmj"},{"key":"3848_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10787-020-00769-5","volume":"29","author":"A Madani Neishaboori","year":"2021","unstructured":"Madani Neishaboori A, Nasseri Maleki S, Saberi Pirouz M, Golmohammadi S, Nazarinia D, Aboutaleb N (2021) Donepezil attenuates injury following ischaemic stroke by stimulation of neurogenesis, angiogenesis, and inhibition of inflammation and apoptosis. Inflammopharmacology 29:153\u2013166","journal-title":"Inflammopharmacology"},{"key":"3848_CR5","first-page":"431","volume":"5","author":"SU Khan","year":"2021","unstructured":"Khan SU, Khan MZ, Khan MU, Khan MS, Mamas MA, Rashid M, Blankstein R, Virani SS, Johansen MC, Shapiro MD (2021) Clinical and economic burden of stroke among young, midlife, and older adults in the United States, 2002\u20132017. Mayo Clin Proc 5:431\u2013441","journal-title":"Mayo Clin Proc"},{"key":"3848_CR6","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1161\/STROKEAHA.106.475483","volume":"38","author":"YS Ng","year":"2007","unstructured":"Ng YS, Stein J, Ning M, Black-Schaffer RM (2007) Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke 38:2309\u20132314","journal-title":"Stroke"},{"key":"3848_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000093574","volume":"55","author":"K Kimura","year":"2006","unstructured":"Kimura K, Minematsu K, Yamaguchi T (2006) Characteristics of in-hospital onset ischemic stroke. Eur Neurol 55:155\u2013159","journal-title":"Eur Neurol"},{"key":"3848_CR8","first-page":"327","volume":"5","author":"K-H Jung","year":"2012","unstructured":"Jung K-H, Lee S-H, Kim BJ, Yu K-H, Hong K-S, Lee B-C, Roh J-K, Group KSRS (2012) Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circulation 5:327\u2013334","journal-title":"Circulation"},{"key":"3848_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1602\/neurorx.1.1.36","volume":"1","author":"YD Cheng","year":"2004","unstructured":"Cheng YD, Al-Khoury L, Zivin JA (2004) Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 1:36\u201345","journal-title":"NeuroRx"},{"key":"3848_CR10","doi-asserted-by":"publisher","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","volume":"335","author":"S Paul","year":"2021","unstructured":"Paul S, Candelario-Jalil E (2021) Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol 335:113518","journal-title":"Exp Neurol"},{"key":"3848_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5853\/jos.2019.00584","volume":"21","author":"JS Kim","year":"2019","unstructured":"Kim JS (2019) tPA helpers in the treatment of acute ischemic stroke: are they ready for clinical use? J Stroke 21:160","journal-title":"J Stroke"},{"key":"3848_CR12","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1073\/pnas.1820799116","volume":"116","author":"AI Casas","year":"2019","unstructured":"Casas AI, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PW, Guney E, Egea J, L\u00f3pez MG, Baumbach J (2019) From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci U S A 116:7129\u20137136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3848_CR13","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/STROKEAHA.117.017320","volume":"48","author":"EA Mistry","year":"2017","unstructured":"Mistry EA, Mistry AM, Nakawah MO, Chitale RV, James RF, Volpi JJ, Fusco MR (2017) Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patients: a meta-analysis. Stroke 48:2450\u20132456","journal-title":"Stroke"},{"key":"3848_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42633-9","volume":"9","author":"H Amani","year":"2019","unstructured":"Amani H, Habibey R, Shokri F, Hajmiresmail SJ, Akhavan O, Mashaghi A, Pazoki-Toroudi H (2019) Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Sci Rep 9:1\u201315","journal-title":"Sci Rep"},{"key":"3848_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2015.06.007","volume":"49","author":"S Won","year":"2015","unstructured":"Won S, Lee J-K, Stein DG (2015) Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia\/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats. Brain Behav Immun 49:267\u2013279","journal-title":"Brain Behav Immun"},{"key":"3848_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/bcpt.12413","volume":"117","author":"M Allahtavakoli","year":"2015","unstructured":"Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D (2015) Ascorbic acid reduces the adverse effects of delayed administration of tissue plasminogen activator in a rat stroke model. Basic Clin Pharmacol Toxicol 117:335\u2013339","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3848_CR17","doi-asserted-by":"publisher","first-page":"e0158848","DOI":"10.1371\/journal.pone.0158848","volume":"11","author":"M-X Dong","year":"2016","unstructured":"Dong M-X, Hu Q-C, Shen P, Pan J-X, Wei Y-D, Liu Y-Y, Ren Y-F, Liang Z-H, Wang H-Y, Zhao L-B (2016) Recombinant tissue plasminogen activator induces neurological side effects independent on thrombolysis in mechanical animal models of focal cerebral infarction: a systematic review and meta-analysis. PLoS ONE 11:e0158848","journal-title":"PLoS ONE"},{"key":"3848_CR18","doi-asserted-by":"publisher","first-page":"111709","DOI":"10.1016\/j.biopha.2021.111709","volume":"140","author":"AA Taei","year":"2021","unstructured":"Taei AA, Nasoohi S, Hassanzadeh G, Kadivar M, Dargahi L, Farahmandfar M (2021) Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model. Biomed Pharmacother 140:111709","journal-title":"Biomed Pharmacother"},{"key":"3848_CR19","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1177\/0271678X211026507","volume":"41","author":"YJ Park","year":"2021","unstructured":"Park YJ, Borlongan CV (2021) Recent advances in cell therapy for stroke. J Cereb Blood Flow Metab 41:2797\u20132799","journal-title":"J Cereb Blood Flow Metab"},{"key":"3848_CR20","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.3390\/ijms21197380","volume":"21","author":"M Kawabori","year":"2020","unstructured":"Kawabori M, Shichinohe H, Kuroda S, Houkin K (2020) Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci 21:7380","journal-title":"Int J Mol Sci"},{"key":"3848_CR21","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1007\/s00415-020-10138-5","volume":"268","author":"J Li","year":"2021","unstructured":"Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J (2021) Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential. J Neurol 268:4095\u20134107","journal-title":"J Neurol"},{"key":"3848_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41551-021-00744-7","volume":"5","author":"Z Lyu","year":"2021","unstructured":"Lyu Z, Park J, Kim K-M, Jin H-J, Wu H, Rajadas J, Kim D-H, Steinberg GK, Lee W (2021) A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke. Nat Biomed Eng 5:847\u2013863","journal-title":"Nat Biomed Eng"},{"key":"3848_CR23","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.1002\/jcb.28207","volume":"120","author":"R Rikhtegar","year":"2019","unstructured":"Rikhtegar R, Yousefi M, Dolati S, Kasmaei HD, Charsouei S, Nouri M, Shakouri SK (2019) Stem cell-based cell therapy for neuroprotection in stroke: a review. J Cell Biochem 120:8849\u20138862","journal-title":"J Cell Biochem"},{"key":"3848_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1515\/REVNEURO.2009.20.1.39","volume":"20","author":"M Janowski","year":"2009","unstructured":"Janowski M, Date I (2009) Systemic neurotransplantation-a problem-oriented systematic review. Rev Neurosci 20:39\u201360","journal-title":"Rev Neurosci"},{"key":"3848_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4612531","author":"TH Shin","year":"2016","unstructured":"Shin TH, Phukan G, Shim JS, Nguyen D-T, Kim Y, Oh-Lee JD, Lee H-S, Paik MJ, Lee G (2016) Restoration of polyamine metabolic patterns in in vivo and in vitro model of ischemic stroke following human mesenchymal stem cell treatment. Stem Cells Int. https:\/\/doi.org\/10.1155\/2016\/4612531","journal-title":"Stem Cells Int"},{"key":"3848_CR26","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/ijms23052550","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Dong N, Hong H, Qi J, Zhang S, Wang J (2022) Mesenchymal stem cells: therapeutic mechanisms for stroke. Int J Mol Sci 23:2550","journal-title":"Int J Mol Sci"},{"key":"3848_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","volume":"11","author":"A Jaillard","year":"2020","unstructured":"Jaillard A, Hommel M, Moisan A, Zeffiro TA, Favre-Wiki IM, Barbieux-Guillot M, Vadot W, Marcel S, Lamalle L, Grand S (2020) Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Transl Stroke Res 11:910\u2013923","journal-title":"Transl Stroke Res"},{"key":"3848_CR28","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","volume":"96","author":"J-W Chung","year":"2021","unstructured":"Chung J-W, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim S-K, Lee JS, Sohn S-I, Kim Y-H, Collaborators S (2021) Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology 96:e1012\u2013e1023","journal-title":"Neurology"},{"key":"3848_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","volume":"82","author":"Q Vu","year":"2014","unstructured":"Vu Q, Xie K, Eckert M, Zhao W, Cramer SC (2014) Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 82:1277\u20131286","journal-title":"Neurology"},{"key":"3848_CR30","first-page":"168","volume":"43","author":"R Kuswardhani","year":"2011","unstructured":"Kuswardhani R, Soejitno A (2011) Bone marrow-derived stem cells as an adjunctive treatment for acute myocardial infarction: a systematic review and meta-analysis. Acta Med Indones 43:168\u2013177","journal-title":"Acta Med Indones"},{"key":"3848_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1747-4949.2012.00797.x","volume":"7","author":"JS Lees","year":"2012","unstructured":"Lees JS, Sena ES, Egan KJ, Antonic A, Koblar SA, Howells DW, Macleod MR (2012) Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke 7:582\u2013588","journal-title":"Int J Stroke"},{"key":"3848_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jcmm.13331","volume":"22","author":"Q Jiang","year":"2018","unstructured":"Jiang Q, Yu T, Huang K, Zhang H, Zheng Z, Hu S (2018) Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning. J Cell Mol Med 22:417\u2013428","journal-title":"J Cell Mol Med"},{"key":"3848_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/scd.2016.0209","volume":"26","author":"L Barrachina","year":"2017","unstructured":"Barrachina L, Remacha AR, Romero A, V\u00e1zquez FJ, Albareda J, Prades M, Gos\u00e1lvez J, Roy R, Zaragoza P, Mart\u00edn-Burriel I (2017) Priming equine bone marrow-derived mesenchymal stem cells with proinflammatory cytokines: implications in immunomodulation\u2013immunogenicity balance, cell viability, and differentiation potential. Stem Cells Dev 26:15\u201324","journal-title":"Stem Cells Dev"},{"key":"3848_CR34","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1177\/0271678X17731964","volume":"38","author":"S Yamaguchi","year":"2018","unstructured":"Yamaguchi S, Horie N, Satoh K, Ishikawa T, Mori T, Maeda H, Fukuda Y, Ishizaka S, Hiu T, Morofuji Y (2018) Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke. J Cereb Blood Flow Metab 38:1199\u20131212","journal-title":"J Cereb Blood Flow Metab"},{"key":"3848_CR35","doi-asserted-by":"publisher","first-page":"101918","DOI":"10.1016\/j.jchemneu.2021.101918","volume":"112","author":"D Nazarinia","year":"2021","unstructured":"Nazarinia D, Sharifi M, Dolatshahi M, Maleki SN, Neishaboori AM, Aboutaleb N (2021) FoxO1 and Wnt\/\u03b2-catenin signaling pathway: molecular targets of human amniotic mesenchymal stem cells-derived conditioned medium (hAMSC-CM) in protection against cerebral ischemia\/reperfusion injury. J Chem Neuroanat 112:101918","journal-title":"J Chem Neuroanat"},{"key":"3848_CR36","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/cns.13886","volume":"28","author":"A Asgari Taei","year":"2022","unstructured":"Asgari Taei A, Dargahi L, Khodabakhsh P, Kadivar M, Farahmandfar M (2022) Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke. CNS Neurosci Ther 28:1425\u20131438","journal-title":"CNS Neurosci Ther"},{"key":"3848_CR37","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/0271678X18776802","volume":"38","author":"CJ Cunningham","year":"2018","unstructured":"Cunningham CJ, Redondo-Castro E, Allan SM (2018) The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab 38:1276\u20131292","journal-title":"J Cereb Blood Flow Metab"},{"key":"3848_CR38","doi-asserted-by":"publisher","first-page":"e5643","DOI":"10.1371\/journal.pone.0005643","volume":"4","author":"S Di Santo","year":"2009","unstructured":"Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS ONE 4:e5643","journal-title":"PLoS ONE"},{"key":"3848_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.brainres.2015.08.003","volume":"1624","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Hu J, Xiang J, Gu Y, Jin P, Hua F, Zhang Z, Liu Y, Zan K, Zhang Z (2015) Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Res 1624:489\u2013496","journal-title":"Brain Res"},{"key":"3848_CR40","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jcyt.2014.05.015","volume":"16","author":"C-M Liang","year":"2014","unstructured":"Liang C-M, Weng S-J, Tsai T-H, Li I-H, Lu P-H, Ma K-H, Tai M-C, Chen J-T, Cheng C-Y, Huang Y-S (2014) Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells. Cytotherapy 16:1371\u20131383","journal-title":"Cytotherapy"},{"key":"3848_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchemneu.2019.02.003","volume":"97","author":"N Aboutaleb","year":"2019","unstructured":"Aboutaleb N, Faezi M, Maleki SN, Nazarinia D, Tousi SMTR, Hashemirad N (2019) Conditioned medium obtained from mesenchymal stem cells attenuates focal cerebral ischemia reperfusion injury through activation of ERK1\/ERK2-BDNF signaling pathway. J Chem Neuroanat 97:87\u201398","journal-title":"J Chem Neuroanat"},{"key":"3848_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2017.02.040","volume":"644","author":"J Xiang","year":"2017","unstructured":"Xiang J, Hu J, Shen T, Liu B, Hua F, Zan K, Zu J, Cui G, Ye X (2017) Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats. Neurosci Lett 644:62\u201366","journal-title":"Neurosci Lett"},{"key":"3848_CR43","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/jcp.29981","volume":"236","author":"A Asgari Taei","year":"2021","unstructured":"Asgari Taei A, Dargahi L, Nasoohi S, Hassanzadeh G, Kadivar M, Farahmandfar M (2021) The conditioned medium of human embryonic stem cell-derived mesenchymal stem cells alleviates neurological deficits and improves synaptic recovery in experimental stroke. J Cell Physiol 236:1967\u20131979","journal-title":"J Cell Physiol"},{"key":"3848_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.brainres.2012.04.033","volume":"1461","author":"Y Egashira","year":"2012","unstructured":"Egashira Y, Sugitani S, Suzuki Y, Mishiro K, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H (2012) The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res 1461:87\u201395","journal-title":"Brain Res"},{"key":"3848_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2018.08.004","volume":"94","author":"M Faezi","year":"2018","unstructured":"Faezi M, Maleki SN, Aboutaleb N, Nikougoftar M (2018) The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis. J Chem Neuroanat 94:21\u201331","journal-title":"J Chem Neuroanat"},{"key":"3848_CR46","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/jnr.23063","volume":"90","author":"YJ Cho","year":"2012","unstructured":"Cho YJ, Song HS, Bhang S, Lee S, Kang BG, Lee JC, An J, Cha CI, Nam DH, Kim BS (2012) Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 90:1794\u20131802","journal-title":"J Neurosci Res"},{"key":"3848_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-21-5","volume":"21","author":"M-J Tsai","year":"2014","unstructured":"Tsai M-J, Tsai S-K, Hu B-R, Liou D-Y, Huang S-L, Huang M-C, Huang W-C, Cheng H, Huang S-S (2014) Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. J Biomed Sci 21:1\u201312","journal-title":"J Biomed Sci"},{"key":"3848_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-1560-y","volume":"11","author":"CJ Cunningham","year":"2020","unstructured":"Cunningham CJ, Wong R, Barrington J, Tamburrano S, Pinteaux E, Allan SM (2020) Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Res Ther 11:1\u201312","journal-title":"Stem Cell Res Ther"},{"key":"3848_CR49","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1080\/01616412.2017.1379293","volume":"39","author":"HG Seo","year":"2017","unstructured":"Seo HG, Yi Y, Oh B-M, Paik N-J (2017) Neuroprotective effect of secreted factors from human adipose stem cells in a rat stroke model. Neurol Res 39:1114\u20131124","journal-title":"Neurol Res"},{"key":"3848_CR50","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/jcp.26931","volume":"234","author":"RH Jiang","year":"2019","unstructured":"Jiang RH, Wu CJ, Xu XQ, Lu SS, Zu QQ, Zhao LB, Wang J, Liu S, Shi HB (2019) Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats. J Cell Physiol 234:1354\u20131368","journal-title":"J Cell Physiol"},{"key":"3848_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/term.3171","volume":"15","author":"MJ Tsai","year":"2021","unstructured":"Tsai MJ, Liou DY, Chu YC, Chen Y, Huang MC, Huang WC, Cheng H, Tsai SK, Huang SS (2021) Minocycline exhibits synergism with conditioned medium of bone marrow mesenchymal stem cells against ischemic stroke. J Tissue Eng Regen Med 15:279\u2013292","journal-title":"J Tissue Eng Regen Med"},{"key":"3848_CR52","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.jchemneu.2019.101707","volume":"102","author":"D Nazarinia","year":"2019","unstructured":"Nazarinia D, Aboutaleb N, Gholamzadeh R, Maleki SN, Mokhtari B, Nikougoftar M (2019) Conditioned medium obtained from human amniotic mesenchymal stem cells attenuates focal cerebral ischemia\/reperfusion injury in rats by targeting mTOR pathway. J Chem Neuroanat 102:101707","journal-title":"J Chem Neuroanat"},{"key":"3848_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02208-3","author":"V Lehnerer","year":"2022","unstructured":"Lehnerer V, Roidl A, Romantsik O, Guzman R, Wellmann S, Bruschettini M (2022) Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-022-02208-3","journal-title":"Pediatr Res"},{"key":"3848_CR54","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.7150\/ijms.74161","volume":"19","author":"H Chen","year":"2022","unstructured":"Chen H, Zhou L (2022) Treatment of ischemic stroke with modified mesenchymal stem cells. Int J Med Sci 19:1155","journal-title":"Int J Med Sci"},{"key":"3848_CR55","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1093\/brain\/awt278","volume":"136","author":"D Tornero","year":"2013","unstructured":"Tornero D, Wattananit S, Gr\u00f8nning Madsen M, Koch P, Wood J, Tatarishvili J, Mine Y, Ge R, Monni E, Devaraju K (2013) Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain 136:3561\u20133577","journal-title":"Brain"},{"key":"3848_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1602\/neurorx.1.4.379","volume":"1","author":"O Lindvall","year":"2004","unstructured":"Lindvall O, Bj\u00f6rklund A (2004) Cell replacement therapy: helping the brain to repair itself. NeuroRx 1:379","journal-title":"NeuroRx"},{"key":"3848_CR57","doi-asserted-by":"publisher","first-page":"146432","DOI":"10.1016\/j.brainres.2019.146432","volume":"1725","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ma L, Su Y, Su L, Lan X, Wu D, Han S, Li J, Kvederis L, Corey S (2019) Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro. Brain Res 1725:146432","journal-title":"Brain Res"},{"key":"3848_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25493","author":"L-l Cui","year":"2019","unstructured":"Cui L-l, Golubczyk D, Tolppanen A-M, Boltze J, Jolkkonen J (2019) Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25493","journal-title":"Ann Neurol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03848-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T16:21:20Z","timestamp":1680279680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3848"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03848-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All protocols were approved by Ethical Committee of Dezful University of Medical Sciences, Dezful, Iran.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}